Summary & Overview
HCPCS J7668: Metaproterenol Inhalation Solution, Concentrated, per 10 mg
HCPCS Level II code J7668 designates FDA-approved metaproterenol sulfate inhalation solution in a concentrated form, billed per 10 milligrams and intended for administration through durable medical equipment. This medication is a bronchodilator delivered via nebulizer systems for patients requiring inhalation therapy; the code documents supply of the non-compounded, final product in a concentrated formulation. Nationally, accurate coding of inhalation solutions impacts pharmacy and DME billing, coverage determinations, and claims processing for respiratory therapies provided in home and outpatient settings.
Key payers covered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for metaproterenol inhalation solution, standard service lines tied to DME-based inhalation therapy, and the typical sites of service where this code is used. The publication also outlines relevant benchmarks and policy considerations affecting coverage and billing for inhalation medications via DME, and highlights areas where payers commonly apply coverage rules or prior authorization for inhalation solutions.
The report is intended to inform billing professionals, clinical administrators, and policy analysts about coding implications, payer coverage patterns, and operational considerations associated with HCPCS Level II code J7668.
Billing Code Overview
HCPCS Level II code J7668 represents metaproterenol sulfate, inhalation solution, FDA-approved final product, non-compounded, administered through durable medical equipment (DME), concentrated form, per 10 milligrams. This code is used to bill for a concentrated inhalation bronchodilator solution provided for administration via DME, such as nebulizer systems, when supplied to a patient.
Service Type: Inhalation medication administration via DME
Typical Site of Service: Home or facility-based use with durable medical equipment (for example, home nebulizer therapy or nebulizer use in outpatient infusion/respiratory therapy settings)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with chronic obstructive pulmonary disease (COPD) and intermittent bronchospasm presents to a durable medical equipment (DME) supplier or outpatient infusion/respiratory clinic for maintenance inhalation therapy. The prescriber orders J7668 (metaproterenol sulfate, inhalation solution, concentrated form, administered through DME, per 10 milligrams) to be dispensed and set up with a nebulizer or compatible DME delivery system. Clinical workflow: medication order from the treating clinician is forwarded to the pharmacy or DME supplier; verification of prescription and insurance eligibility is completed; the concentrated metaproterenol solution is dispensed in appropriate vial quantities with labeling; patient education on nebulizer assembly, dosing, and adverse effects is provided by a respiratory therapist or DME clinician; documentation of delivery, device setup, and patient instruction is placed in the medical record; claims submission includes J7668 with applicable modifiers reflecting payer requirements and the site of service documented as outpatient DME supply or home use with DME support.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard claim submission | Use when no special circumstances apply. |